Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Dec 15;352(Pt 3):817–826.

Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C.

G Wang 1, Y L Siow 1, K O 1
PMCID: PMC1221522  PMID: 11104691

Abstract

Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine that stimulates the migration of monocytes into the intima of arterial walls. Although many factors that induce MCP-1 expression have been identified, the effect of homocysteine on the expression of MCP-1 in atherogenesis and the underlying mechanisms are not entirely clear. The objective of the present study was to investigate the role of homocysteine in MCP-1 expression in human aorta vascular smooth-muscle cells (VSMCs). After VSMCs were incubated with homocysteine for various time periods, a nuclease protection assay and ELISA were performed. Homocysteine (0.05-0.2 mM) significantly increased the expression of MCP-1 mRNA (up to 2. 7-fold) and protein (up to 3.3-fold) in these cells. The increase in MCP-1 expression was associated with the activation of protein kinase C (PKC) as well as nuclear factor kappaB (NF-kappaB). Further investigation demonstrated that the activation of NF-kappaB was the result of a PKC-mediated reduction in the expression of inhibitory protein (IkappaBalpha) mRNA and protein in homocysteine-treated cells. Oxidative stress might also be involved in the activation of NF-kappaB by homocysteine in VSMCs. In conclusion, the present study has clearly demonstrated that the activation of PKC as well as superoxide production followed by activation of NF-kappaB is responsible for homocysteine-induced MCP-1 expression in VSMCs. These results suggest that homocysteine-stimulated MCP-1 expression via NF-kappaB activation may play an important role in atherogenesis.

Full Text

The Full Text of this article is available as a PDF (366.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin A. S., Jr The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–683. doi: 10.1146/annurev.immunol.14.1.649. [DOI] [PubMed] [Google Scholar]
  2. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kaltschmidt C., Baeuerle P. A., Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996 Apr 1;97(7):1715–1722. doi: 10.1172/JCI118598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brand K., Page S., Walli A. K., Neumeier D., Baeuerle P. A. Role of nuclear factor-kappa B in atherogenesis. Exp Physiol. 1997 Mar;82(2):297–304. doi: 10.1113/expphysiol.1997.sp004025. [DOI] [PubMed] [Google Scholar]
  4. Brown Z., Gerritsen M. E., Carley W. W., Strieter R. M., Kunkel S. L., Westwick J. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am J Pathol. 1994 Oct;145(4):913–921. [PMC free article] [PubMed] [Google Scholar]
  5. Chen Z. J., Parent L., Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell. 1996 Mar 22;84(6):853–862. doi: 10.1016/s0092-8674(00)81064-8. [DOI] [PubMed] [Google Scholar]
  6. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991 Apr 25;324(17):1149–1155. doi: 10.1056/NEJM199104253241701. [DOI] [PubMed] [Google Scholar]
  7. Dichtl W., Nilsson L., Goncalves I., Ares M. P., Banfi C., Calara F., Hamsten A., Eriksson P., Nilsson J. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. Circ Res. 1999 May 14;84(9):1085–1094. doi: 10.1161/01.res.84.9.1085. [DOI] [PubMed] [Google Scholar]
  8. Duell P. B., Malinow M. R. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol. 1997 Feb;8(1):28–34. doi: 10.1097/00041433-199702000-00007. [DOI] [PubMed] [Google Scholar]
  9. Eickelberg O., Roth M., Mussmann R., Rüdiger J. J., Tamm M., Perruchoud A. P., Block L. H. Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells. Circulation. 1999 May 4;99(17):2276–2282. doi: 10.1161/01.cir.99.17.2276. [DOI] [PubMed] [Google Scholar]
  10. Erl W., Hansson G. K., de Martin R., Draude G., Weber K. S., Weber C. Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res. 1999 Apr 2;84(6):668–677. doi: 10.1161/01.res.84.6.668. [DOI] [PubMed] [Google Scholar]
  11. Faggiotto A., Ross R., Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis. 1984 Jul-Aug;4(4):323–340. doi: 10.1161/01.atv.4.4.323. [DOI] [PubMed] [Google Scholar]
  12. Fang X., Weintraub N. L., Stoll L. L., Spector A. A. Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells. Hypertension. 1999 Dec;34(6):1242–1246. doi: 10.1161/01.hyp.34.6.1242. [DOI] [PubMed] [Google Scholar]
  13. Gerrity R. G. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981 May;103(2):181–190. [PMC free article] [PubMed] [Google Scholar]
  14. Harker L. A., Ross R., Slichter S. J., Scott C. R. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976 Sep;58(3):731–741. doi: 10.1172/JCI108520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harker L. A., Slichter S. J., Scott C. R., Ross R. Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med. 1974 Sep 12;291(11):537–543. doi: 10.1056/NEJM197409122911101. [DOI] [PubMed] [Google Scholar]
  16. Hishikawa K., Oemar B. S., Yang Z., Lüscher T. F. Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. Circ Res. 1997 Nov;81(5):797–803. doi: 10.1161/01.res.81.5.797. [DOI] [PubMed] [Google Scholar]
  17. Ikeda U., Ikeda M., Minota S., Shimada K. Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells. Circulation. 1999 Mar 9;99(9):1230–1235. doi: 10.1161/01.cir.99.9.1230. [DOI] [PubMed] [Google Scholar]
  18. Landry D. B., Couper L. L., Bryant S. R., Lindner V. Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am J Pathol. 1997 Oct;151(4):1085–1095. [PMC free article] [PubMed] [Google Scholar]
  19. Li Y. S., Shyy Y. J., Wright J. G., Valente A. J., Cornhill J. F., Kolattukudy P. E. The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo. Mol Cell Biochem. 1993 Sep 8;126(1):61–68. doi: 10.1007/BF01772208. [DOI] [PubMed] [Google Scholar]
  20. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 1996 Jul 1;98(1):5–7. doi: 10.1172/JCI118776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lynn E. G., Siow Y. L., O K. Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells. Kidney Int. 2000 Apr;57(4):1472–1483. doi: 10.1046/j.1523-1755.2000.00992.x. [DOI] [PubMed] [Google Scholar]
  22. Malinow M. R., Bostom A. G., Krauss R. M. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1999 Jan 5;99(1):178–182. doi: 10.1161/01.cir.99.1.178. [DOI] [PubMed] [Google Scholar]
  23. Marumo T., Schini-Kerth V. B., Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes. 1999 May;48(5):1131–1137. doi: 10.2337/diabetes.48.5.1131. [DOI] [PubMed] [Google Scholar]
  24. Marumo T., Schini-Kerth V. B., Fisslthaler B., Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation. 1997 Oct 7;96(7):2361–2367. doi: 10.1161/01.cir.96.7.2361. [DOI] [PubMed] [Google Scholar]
  25. McCully K. S. Homocysteine and vascular disease. Nat Med. 1996 Apr;2(4):386–389. doi: 10.1038/nm0496-386. [DOI] [PubMed] [Google Scholar]
  26. Mujumdar V. S., Hayden M. R., Tyagi S. C. Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells. J Cell Physiol. 2000 Apr;183(1):28–36. doi: 10.1002/(SICI)1097-4652(200004)183:1<28::AID-JCP4>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  27. Muniyappa R., Srinivas P. R., Ram J. L., Walsh M. F., Sowers J. R. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension. 1998 Jan;31(1 Pt 2):289–295. doi: 10.1161/01.hyp.31.1.289. [DOI] [PubMed] [Google Scholar]
  28. Nakagawa T., Nozaki S., Nishida M., Yakub J. M., Tomiyama Y., Nakata A., Matsumoto K., Funahashi T., Kameda-Takemura K., Kurata Y. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1350–1357. doi: 10.1161/01.atv.18.8.1350. [DOI] [PubMed] [Google Scholar]
  29. Negus R. P., Stamp G. W., Relf M. G., Burke F., Malik S. T., Bernasconi S., Allavena P., Sozzani S., Mantovani A., Balkwill F. R. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest. 1995 May;95(5):2391–2396. doi: 10.1172/JCI117933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Nelken N. A., Coughlin S. R., Gordon D., Wilcox J. N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 1991 Oct;88(4):1121–1127. doi: 10.1172/JCI115411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. O K., Lynn E. G., Chung Y. H., Siow Y. L., Man R. Y., Choy P. C. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Biophys Acta. 1998 Aug 28;1393(2-3):317–324. doi: 10.1016/s0005-2760(98)00086-1. [DOI] [PubMed] [Google Scholar]
  32. Parry G. C., Martin T., Felts K. A., Cobb R. R. IL-1beta-induced monocyte chemoattractant protein-1 gene expression in endothelial cells is blocked by proteasome inhibitors. Arterioscler Thromb Vasc Biol. 1998 Jun;18(6):934–940. doi: 10.1161/01.atv.18.6.934. [DOI] [PubMed] [Google Scholar]
  33. Pueyo M. E., Gonzalez W., Nicoletti A., Savoie F., Arnal J. F., Michel J. B. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):645–651. doi: 10.1161/01.atv.20.3.645. [DOI] [PubMed] [Google Scholar]
  34. Reape T. J., Groot P. H. Chemokines and atherosclerosis. Atherosclerosis. 1999 Dec;147(2):213–225. doi: 10.1016/s0021-9150(99)00346-9. [DOI] [PubMed] [Google Scholar]
  35. Refsum H., Ueland P. M., Nygård O., Vollset S. E. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31–62. doi: 10.1146/annurev.med.49.1.31. [DOI] [PubMed] [Google Scholar]
  36. Rollins B. J., Yoshimura T., Leonard E. J., Pober J. S. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol. 1990 Jun;136(6):1229–1233. [PMC free article] [PubMed] [Google Scholar]
  37. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  38. Schreiber E., Matthias P., Müller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989 Aug 11;17(15):6419–6419. doi: 10.1093/nar/17.15.6419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Simeonidis S., Stauber D., Chen G., Hendrickson W. A., Thanos D. Mechanisms by which IkappaB proteins control NF-kappaB activity. Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):49–54. doi: 10.1073/pnas.96.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Starkebaum G., Harlan J. M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986 Apr;77(4):1370–1376. doi: 10.1172/JCI112442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sugiyama S., Kugiyama K., Ogata N., Doi H., Ota Y., Ohgushi M., Matsumura T., Oka H., Yasue H. Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):568–576. doi: 10.1161/01.atv.18.4.568. [DOI] [PubMed] [Google Scholar]
  42. Takeya M., Yoshimura T., Leonard E. J., Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol. 1993 May;24(5):534–539. doi: 10.1016/0046-8177(93)90166-e. [DOI] [PubMed] [Google Scholar]
  43. Thurberg B. L., Collins T. The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. Curr Opin Lipidol. 1998 Oct;9(5):387–396. doi: 10.1097/00041433-199810000-00002. [DOI] [PubMed] [Google Scholar]
  44. Ueda A., Ishigatsubo Y., Okubo T., Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem. 1997 Dec 5;272(49):31092–31099. doi: 10.1074/jbc.272.49.31092. [DOI] [PubMed] [Google Scholar]
  45. Welch G. N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998 Apr 9;338(15):1042–1050. doi: 10.1056/NEJM199804093381507. [DOI] [PubMed] [Google Scholar]
  46. Wilcken D. E., Wang X. L., Adachi T., Hara H., Duarte N., Green K., Wilcken B. Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler Thromb Vasc Biol. 2000 May;20(5):1199–1202. doi: 10.1161/01.atv.20.5.1199. [DOI] [PubMed] [Google Scholar]
  47. Wilkinson S. E., Parker P. J., Nixon J. S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J. 1993 Sep 1;294(Pt 2):335–337. doi: 10.1042/bj2940335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Ylä-Herttuala S., Lipton B. A., Rosenfeld M. E., Särkioja T., Yoshimura T., Leonard E. J., Witztum J. L., Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5252–5256. doi: 10.1073/pnas.88.12.5252. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES